Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TESARO, Inc.TSRO · Entity 160894 | VP of Finance & Administration | September 06, 2017 | September 06, 2017 |
| Xilio Therapeutics, Inc.XLO · Entity 7122 | PRINCIPAL ACCOUNTING OFFICER | January 01, 2023 | January 04, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TESARO, Inc.
Report date September 06, 2017 · Filed September 06, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001SEC Table I · non-derivative | Direct | 396 |
Ending reported balance
After 2017-09-06 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2017-09-06 · Exercise / conversion · Acquired 5,862 · Balance 6,258 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Row 2 · 2017-09-06 · Exercise / conversion · Acquired 5,000 · Balance 11,258 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Row 3 · 2017-09-06 · Sale · Disposed 5,460 · Balance 5,798 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2: The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $134.03 to $135.02, inclusive. The reporting person undertakes to provide to TESARO, Inc., any security holder of TESARO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Row 4 · 2017-09-06 · Sale · Disposed 5,102 · Balance 696 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3: The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $135.03 to $135.94, inclusive. The reporting person undertakes to provide to TESARO, Inc., any security holder of TESARO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Row 5 · 2017-09-06 · Sale · Disposed 300 · Balance 396 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4: The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $136.09 to $136.43, inclusive. The reporting person undertakes to provide to TESARO, Inc., any security holder of TESARO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $24.18 · Expires 2023-03-06 | Direct | 4,138 |
Reported balance
After 2017-09-06 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-09-06 · Exercise / conversion · Disposed 5,862 · Balance 4,138 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5: A quarter of the original grant of options to purchase 25,000 shares of common stock vested on March 6, 2014 and, thereafter, 1/36th of the remaining options vested on each monthly anniversary of such date until fully vested. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $55.11 · Expires 2025-03-06 | Direct | 20,000 |
Reported balance
After 2017-09-06 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-09-06 · Exercise / conversion · Disposed 5,000 · Balance 20,000 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6: The option to purchase 25,000 shares of common stock vests in 48 equal monthly installments beginning on April 6, 2015. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $134.03 to $135.02, inclusive. The reporting person undertakes to provide to TESARO, Inc., any security holder of TESARO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3: The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $135.03 to $135.94, inclusive. The reporting person undertakes to provide to TESARO, Inc., any security holder of TESARO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4: The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $136.09 to $136.43, inclusive. The reporting person undertakes to provide to TESARO, Inc., any security holder of TESARO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F5: A quarter of the original grant of options to purchase 25,000 shares of common stock vested on March 6, 2014 and, thereafter, 1/36th of the remaining options vested on each monthly anniversary of such date until fully vested.
F6: The option to purchase 25,000 shares of common stock vests in 48 equal monthly installments beginning on April 6, 2015.
Xilio Therapeutics, Inc.
Report date January 01, 2023 · Filed January 04, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.69 · Expires 2032-12-31 | Direct | 24,000 |
Reported balance
After 2023-01-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-01-01 · Grant · Acquired 24,000 · Balance 24,000 F1: The option award was granted on January 1, 2023 and shall vest on February 1, 2023 with respect to 1/48th of the shares of common stock underlying the stock option and shall continue to vest in equal monthly installments thereafter until January 1, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: The option award was granted on January 1, 2023 and shall vest on February 1, 2023 with respect to 1/48th of the shares of common stock underlying the stock option and shall continue to vest in equal monthly installments thereafter until January 1, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 01, 2023 Filed Jan 4, 2023 16:09 UTC | Xilio Therapeutics, Inc. XLO · Entity 7122 | GrantStock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $2.69 | $0.00 |
DisclosureSEC source: 0001415889-23-000282 · form4-01042023_090144.xml · derivative · entry 1 English Edward C · CIK 0001302600 · PRINCIPAL ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2032-12-31 F1 · derivative.exercise_date: The option award was granted on January 1, 2023 and shall vest on February 1, 2023 with respect to 1/48th of the shares of common stock underlying the stock option and shall continue to vest in equal monthly installments thereafter until January 1, 2027. Read SEC document |
| September 06, 2017 Filed Sep 6, 2017 21:00 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $55.11 | $0.00 |
DisclosureSEC source: 0001104659-17-055903 · a4.xml · derivative · entry 7 English Edward C · CIK 0001302600 · VP of Finance & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 5,000 shares Expires 2025-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · derivative.exercise_date: The option to purchase 25,000 shares of common stock vests in 48 equal monthly installments beginning on April 6, 2015. Read SEC document |
| September 06, 2017 Filed Sep 6, 2017 21:00 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,862 | $0.00 Strike: $24.18 | $0.00 |
DisclosureSEC source: 0001104659-17-055903 · a4.xml · derivative · entry 6 English Edward C · CIK 0001302600 · VP of Finance & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,138 Underlying: Common Stock · 5,862 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: A quarter of the original grant of options to purchase 25,000 shares of common stock vested on March 6, 2014 and, thereafter, 1/36th of the remaining options vested on each monthly anniversary of such date until fully vested. Read SEC document |
| September 06, 2017 Filed Sep 6, 2017 21:00 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock, par value $0.0001 | 300 | $136.26 | $40,878.00 |
DisclosureSEC source: 0001104659-17-055903 · a4.xml · nonDerivative · entry 5 English Edward C · CIK 0001302600 · VP of Finance & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 396 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $136.09 to $136.43, inclusive. The reporting person undertakes to provide to TESARO, Inc., any security holder of TESARO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 06, 2017 Filed Sep 6, 2017 21:00 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock, par value $0.0001 | 5,102 | $135.40 | $690,810.80 |
DisclosureSEC source: 0001104659-17-055903 · a4.xml · nonDerivative · entry 4 English Edward C · CIK 0001302600 · VP of Finance & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 696 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $135.03 to $135.94, inclusive. The reporting person undertakes to provide to TESARO, Inc., any security holder of TESARO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 06, 2017 Filed Sep 6, 2017 21:00 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock, par value $0.0001 | 5,460 | $134.39 | $733,769.40 |
DisclosureSEC source: 0001104659-17-055903 · a4.xml · nonDerivative · entry 3 English Edward C · CIK 0001302600 · VP of Finance & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,798 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $134.03 to $135.02, inclusive. The reporting person undertakes to provide to TESARO, Inc., any security holder of TESARO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 06, 2017 Filed Sep 6, 2017 21:00 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock, par value $0.0001 | 5,000 | $55.11 | $275,550.00 |
DisclosureSEC source: 0001104659-17-055903 · a4.xml · nonDerivative · entry 2 English Edward C · CIK 0001302600 · VP of Finance & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 06, 2017 Filed Sep 6, 2017 21:00 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock, par value $0.0001 | 5,862 | $24.18 | $141,743.16 |
DisclosureSEC source: 0001104659-17-055903 · a4.xml · nonDerivative · entry 1 English Edward C · CIK 0001302600 · VP of Finance & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 06, 2017 Filed Jun 8, 2017 17:18 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,500 | $0.00 Strike: $33.74 | $0.00 |
DisclosureSEC source: 0001104659-17-038204 · a4.xml · derivative · entry 8 English Edward C · CIK 0001302600 · VP of Finance & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 3,500 shares Expires 2024-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2016. F7 · derivative.exercise_date: A quarter of the original grant of options to purchase 25,000 shares of common stock vested on February 27, 2015 and, thereafter, 1/36th of the remaining options vest on each monthly anniversary of such date until fully vested. Read SEC document |
| June 06, 2017 Filed Jun 8, 2017 17:18 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $24.18 | $0.00 |
DisclosureSEC source: 0001104659-17-038204 · a4.xml · derivative · entry 7 English Edward C · CIK 0001302600 · VP of Finance & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 5,000 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2016. F6 · derivative.exercise_date: A quarter of the original grant of options to purchase 25,000 shares of common stock vested on March 6, 2014 and, thereafter, 1/36th of the remaining options vested on each monthly anniversary of such date until fully vested. Read SEC document |
| June 06, 2017 Filed Jun 8, 2017 17:18 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock, par value $0.0001 | 362 | $142.16 | $51,461.92 |
DisclosureSEC source: 0001104659-17-038204 · a4.xml · nonDerivative · entry 6 English Edward C · CIK 0001302600 · VP of Finance & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 396 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2016. F5 · price: The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $141.85 to $142.42, inclusive. The reporting person undertakes to provide to TESARO, Inc., any security holder of TESARO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 06, 2017 Filed Jun 8, 2017 17:18 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock, par value $0.0001 | 638 | $140.05 | $89,351.90 |
DisclosureSEC source: 0001104659-17-038204 · a4.xml · nonDerivative · entry 5 English Edward C · CIK 0001302600 · VP of Finance & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 758 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2016. F4 · price: The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $139.45 to $140.36, inclusive. The reporting person undertakes to provide to TESARO, Inc., any security holder of TESARO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 06, 2017 Filed Jun 8, 2017 17:18 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock, par value $0.0001 | 3,400 | $138.82 | $471,988.00 |
DisclosureSEC source: 0001104659-17-038204 · a4.xml · nonDerivative · entry 4 English Edward C · CIK 0001302600 · VP of Finance & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,396 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2016. F3 · price: The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $138.38 to $139.35, inclusive. The reporting person undertakes to provide to TESARO, Inc., any security holder of TESARO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 06, 2017 Filed Jun 8, 2017 17:18 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock, par value $0.0001 | 4,100 | $137.98 | $565,718.00 |
DisclosureSEC source: 0001104659-17-038204 · a4.xml · nonDerivative · entry 3 English Edward C · CIK 0001302600 · VP of Finance & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,796 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2016. F2 · price: The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $137.38 to $138.37, inclusive. The reporting person undertakes to provide to TESARO, Inc., any security holder of TESARO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 06, 2017 Filed Jun 8, 2017 17:18 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock, par value $0.0001 | 3,500 | $33.74 | $118,090.00 |
DisclosureSEC source: 0001104659-17-038204 · a4.xml · nonDerivative · entry 2 English Edward C · CIK 0001302600 · VP of Finance & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2016. Read SEC document |
| June 06, 2017 Filed Jun 8, 2017 17:18 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock, par value $0.0001 | 5,000 | $24.18 | $120,900.00 |
DisclosureSEC source: 0001104659-17-038204 · a4.xml · nonDerivative · entry 1 English Edward C · CIK 0001302600 · VP of Finance & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,396 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2016. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 17:17 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $33.74 | $0.00 |
DisclosureSEC source: 0001104659-17-015228 · a4.xml · derivative · entry 5 English Edward C · CIK 0001302600 · V.P. of Finance & Admin. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500 Underlying: Common Stock · 5,000 shares Expires 2024-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2016. F3 · derivative.exercise_date: A quarter of the original grant of options to purchase 25,000 shares of common stock vested on February 27, 2015 and, thereafter, 1/36th of the remaining options vest on each monthly anniversary of such date until fully vested. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 17:17 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $24.18 | $0.00 |
DisclosureSEC source: 0001104659-17-015228 · a4.xml · derivative · entry 4 English Edward C · CIK 0001302600 · V.P. of Finance & Admin. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 5,000 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2016. F2 · derivative.exercise_date: A quarter of the original grant of options to purchase 25,000 shares of common stock vested on March 6, 2014 and, thereafter, 1/36th of the remaining options vested on each monthly anniversary of such date until fully vested. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 17:17 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock, par value $.0001 | 10,000 | $178.06 | $1,780,600.00 |
DisclosureSEC source: 0001104659-17-015228 · a4.xml · nonDerivative · entry 3 English Edward C · CIK 0001302600 · V.P. of Finance & Admin. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 396 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2016. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 17:17 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock, par value $.0001 | 5,000 | $33.74 | $168,700.00 |
DisclosureSEC source: 0001104659-17-015228 · a4.xml · nonDerivative · entry 2 English Edward C · CIK 0001302600 · V.P. of Finance & Admin. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,396 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2016. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 17:17 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock, par value $.0001 | 5,000 | $24.18 | $120,900.00 |
DisclosureSEC source: 0001104659-17-015228 · a4.xml · nonDerivative · entry 1 English Edward C · CIK 0001302600 · V.P. of Finance & Admin. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,396 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2016. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 17:15 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock | 229 | $177.61 | $40,672.69 |
DisclosureSEC source: 0001104659-17-014107 · a4.xml · nonDerivative · entry 2 English Edward C · CIK 0001302600 · VP of Finance & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 396 F1 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 17:15 UTC | TESARO, Inc. TSRO · Entity 160894 | GrantEmployee Stock Option (right to buy) · Derivative | 2,150 | $0.00 Strike: $178.95 | $0.00 |
DisclosureSEC source: 0001104659-17-014107 · a4.xml · derivative · entry 5 English Edward C · CIK 0001302600 · VP of Finance & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,150 Underlying: Common Stock · 2,150 shares Expires 2027-03-01 F5 · derivative.exercise_date: The option vests in 48 equal monthly installments beginning on April 1, 2017. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 17:15 UTC | TESARO, Inc. TSRO · Entity 160894 | GrantRestricted Stock Units · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-014107 · a4.xml · derivative · entry 4 English Edward C · CIK 0001302600 · VP of Finance & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F4 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on March 1, 2018. F4 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on March 1, 2018. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 17:15 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionRestricted Stock Units · Derivative | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-014107 · a4.xml · derivative · entry 3 English Edward C · CIK 0001302600 · VP of Finance & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 Underlying: Common Stock · 625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F3 · derivative.exercise_date: The restricted stock units were granted on March 1, 2016 and vest in four equal annual installments beginning on March 1, 2017. F3 · derivative.expiration_date: The restricted stock units were granted on March 1, 2016 and vest in four equal annual installments beginning on March 1, 2017. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 17:15 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-014107 · a4.xml · nonDerivative · entry 1 English Edward C · CIK 0001302600 · VP of Finance & Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 16:17 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $34.58 | $0.00 |
DisclosureSEC source: 0001104659-16-162074 · a4.xml · derivative · entry 6 English Edward C · CIK 0001302600 · VP of Finance and Admin. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2023-08-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2016. F5 · derivative.exercise_date: A quarter of the original grant of options to purchase 15,000 shares of common stock vested on August 30, 2014 and, thereafter, 1/36th of the remaining options vest on each monthly anniversary of such date until fully vested. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 16:17 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $24.18 | $0.00 |
DisclosureSEC source: 0001104659-16-162074 · a4.xml · derivative · entry 5 English Edward C · CIK 0001302600 · VP of Finance and Admin. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 5,000 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2016. F4 · derivative.exercise_date: A quarter of the original grant of options to purchase 25,000 shares of common stock vested on March 6, 2014 and, thereafter, 1/36th of the remaining options vest on each monthly anniversary of such date until fully vested. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 16:17 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock, par value $.0001 | 8,300 | $129.20 | $1,072,360.00 |
DisclosureSEC source: 0001104659-16-162074 · a4.xml · nonDerivative · entry 4 English Edward C · CIK 0001302600 · VP of Finance and Admin. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2016. F3 · price: The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $128.82 to $129.67, inclusive. The reporting person undertakes to provide to TESARO, Inc., any security holder of TESARO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 16:17 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock, par value $.0001 | 1,700 | $128.30 | $218,110.00 |
DisclosureSEC source: 0001104659-16-162074 · a4.xml · nonDerivative · entry 3 English Edward C · CIK 0001302600 · VP of Finance and Admin. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,300 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2016. F2 · price: The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $127.79 to $128.73, inclusive. The reporting person undertakes to provide to TESARO, Inc., any security holder of TESARO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 16:17 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock, par value $.0001 | 5,000 | $34.58 | $172,900.00 |
DisclosureSEC source: 0001104659-16-162074 · a4.xml · nonDerivative · entry 2 English Edward C · CIK 0001302600 · VP of Finance and Admin. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2016. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 16:17 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock, par value $.0001 | 5,000 | $24.18 | $120,900.00 |
DisclosureSEC source: 0001104659-16-162074 · a4.xml · nonDerivative · entry 1 English Edward C · CIK 0001302600 · VP of Finance and Admin. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2016. Read SEC document |
| September 08, 2016 Filed Sep 9, 2016 17:01 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,500 | $0.00 Strike: $33.74 | $0.00 |
DisclosureSEC source: 0001104659-16-144014 · a4.xml · derivative · entry 7 English Edward C · CIK 0001302600 · V.P.Finance and Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 3,500 shares Expires 2024-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2015. F5 · derivative.exercise_date: A quarter of the original grant of options to purchase 25,000 shares of common stock vested on February 27, 2015 and, thereafter, 1/36th of the remaining options vest on each monthly anniversary of such date until fully vested. Read SEC document |
| September 08, 2016 Filed Sep 9, 2016 17:01 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,500 | $0.00 Strike: $13.31 | $0.00 |
DisclosureSEC source: 0001104659-16-144014 · a4.xml · derivative · entry 6 English Edward C · CIK 0001302600 · V.P.Finance and Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,072 Underlying: Common Stock · 3,500 shares Expires 2022-09-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2015. F4 · derivative.exercise_date: A quarter of the original grant of options to purchase 28,672 shares of common stock vested on June 11, 2013 and, thereafter, 1/36th of the remaining options vested on each monthly anniversary of such date until fully vested. Read SEC document |
| September 08, 2016 Filed Sep 9, 2016 17:01 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock, par value $.01 | 1,500 | $90.47 | $135,705.00 |
DisclosureSEC source: 0001104659-16-144014 · a4.xml · nonDerivative · entry 5 English Edward C · CIK 0001302600 · V.P.Finance and Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2015. F3 · price: The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $90.44 to $90.61, inclusive. The reporting person undertakes to provide to TESARO, Inc., any security holder of TESARO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 08, 2016 Filed Sep 9, 2016 17:01 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock, par value $.01 | 100 | $88.98 | $8,898.00 |
DisclosureSEC source: 0001104659-16-144014 · a4.xml · nonDerivative · entry 4 English Edward C · CIK 0001302600 · V.P.Finance and Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2015. Read SEC document |
| September 08, 2016 Filed Sep 9, 2016 17:01 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock, par value $.01 | 5,400 | $88.00 | $475,200.00 |
DisclosureSEC source: 0001104659-16-144014 · a4.xml · nonDerivative · entry 3 English Edward C · CIK 0001302600 · V.P.Finance and Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2015. F2 · price: The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $87.52 to $88.35, inclusive. The reporting person undertakes to provide to TESARO, Inc., any security holder of TESARO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 08, 2016 Filed Sep 9, 2016 17:01 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock, par value $.01 | 3,500 | $33.74 | $118,090.00 |
DisclosureSEC source: 0001104659-16-144014 · a4.xml · nonDerivative · entry 2 English Edward C · CIK 0001302600 · V.P.Finance and Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2015. Read SEC document |
| September 08, 2016 Filed Sep 9, 2016 17:01 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock, par value $.01 | 3,500 | $13.31 | $46,585.00 |
DisclosureSEC source: 0001104659-16-144014 · a4.xml · nonDerivative · entry 1 English Edward C · CIK 0001302600 · V.P.Finance and Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2015. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.